Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 2:24 pm Unchanged |
2024-09-30 | 13G | TNF Pharmaceuticals, Inc. TNFA |
Global X Management CO LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-05-30 4:05 pm Purchase |
2024-05-23 | 13D | MyMD Pharmaceuticals, Inc. MYMD |
PharmaCyte Biotech Inc. PMCB |
11,563,878 83.400% |
11,563,878 (New Position) |
Filing History |
| 2024-02-14 3:13 pm Purchase |
2023-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD |
Global X Management CO LLC | 103,616 6.110% |
103,616 (New Position) |
Filing History |
| 2024-02-14 11:27 am Purchase |
2023-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD |
Iroquois Capital Management, LLC | 168,853 4.990% |
109,815 (+186.01%) |
Filing History |
| 2023-02-14 07:40 am Sale |
2022-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD |
Iroquois Capital Management, LLC | 59,038 6.470% |
-13,582 (-18.70%) |
Filing History |
| 2022-09-08 4:22 pm Purchase |
2022-06-07 | 13D | MyMD Pharmaceuticals, Inc. MYMD |
DUFFEY SAMUEL S | 74,727 5.860% |
74,727 (New Position) |
Filing History |
| 2022-02-23 4:45 pm Purchase |
2021-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD |
Iroquois Capital Management, LLC | 72,620 9.560% |
72,620 (New Position) |
Filing History |
| 2022-02-11 07:17 am Purchase |
2021-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD |
Mitchell P. Kopin | 12,165 1.000% |
12,165 (New Position) |
Filing History |
| 2022-01-11 4:30 pm Unchanged |
2021-12-31 | 13G | MyMD Pharmaceuticals, Inc. MYMD |
MAINFIELD ENTERPRISES INC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-04-26 6:29 pm Purchase |
2021-04-16 | 13D | MyMD Pharmaceuticals, Inc. MYMD |
Williams Caroline C | 167,339 13.160% |
167,339 (New Position) |
Filing History |
| 2021-02-22 09:56 am Purchase |
2020-12-31 | 13G | TNF Pharmaceuticals, Inc. TNFA |
Iroquois Capital Management, LLC | 52,027 9.990% |
17,101 (+48.96%) |
Filing History |
| 2021-02-18 2:22 pm Purchase |
2020-11-17 | 13G | TNF Pharmaceuticals, Inc. TNFA |
MAINFIELD ENTERPRISES INC | 18,018 5.800% |
18,018 (New Position) |
Filing History |
| 2021-01-29 06:31 am Unchanged |
2020-12-31 | 13G | TNF Pharmaceuticals, Inc. TNFA |
Mitchell P. Kopin | 24,324 7.500% |
0 (Unchanged) |
Filing History |
| 2020-11-20 4:06 pm Purchase |
2020-11-17 | 13G | TNF Pharmaceuticals, Inc. TNFA |
Mitchell P. Kopin | 24,324 7.500% |
24,321 (+748340.00%) |
Filing History |
| 2020-11-19 08:16 am Purchase |
2020-11-17 | 13G | TNF Pharmaceuticals, Inc. TNFA |
Iroquois Capital Management, LLC | 34,926 9.990% |
34,926 (New Position) |
Filing History |
| 2020-05-26 06:23 am Unchanged |
2020-05-14 | 13G | TNF Pharmaceuticals, Inc. TNFA |
Mitchell P. Kopin | 3 0.003% |
0 (Unchanged) |
Filing History |
| 2020-05-05 2:15 pm Sale |
2020-04-30 | 13G | TNF Pharmaceuticals, Inc. TNFA |
Hudson Bay Capital Management LP | 31 0.040% |
-4,456 (-99.30%) |
Filing History |